dimethyl fumarate
Selected indexed studies
- Dimethyl Fumarate: A Review in Relapsing-Remitting MS. (Drugs, 2019) [PMID:31784875]
- Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. (Science, 2018) [PMID:29599194]
- Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer's disease. (J Neuroinflammation, 2024) [PMID:38383481]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dimethyl Fumarate: A Review in Relapsing-Remitting MS. (2019) pubmed
- Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. (2018) pubmed
- Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer's disease. (2024) pubmed
- Dimethyl Fumarate for Pediatric-Onset Multiple Sclerosis: A Systematic Review. (2025) pubmed
- Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases. (2022) pubmed
- Dimethyl Fumarate and Intestine: From Main Suspect to Potential Ally against Gut Disorders. (2023) pubmed
- Dimethyl fumarate, a two-edged drug: Current status and future directions. (2019) pubmed
- Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature. (2021) pubmed
- Dimethyl fumarate induced migrating polyarthralgias. (2019) pubmed
- Dimethyl Fumarate Suppresses Collagen-Induced Arthritis by Regulating Inflammatory Responses. (2025) pubmed